Redirecting our immune cells to help fight children's cancer

November 6, 2013, Cancer Research UK
Redirecting our immune cells to help fight children's cancer

Immune cells, known as Natural Killer T cells, could be redirected to help fight the childhood cancer, neuroblastoma, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool (Tuesday).

By genetically modifying human Natural Killer T (NKT) so that they recognise as being dangerous, researchers managed to achieve long-lasting remission - and in some instances cures - of mice that carried highly aggressive human neuroblastoma.

NKT cells are specialised which respond quickly to danger, such as an infection or , and help kick-start an to protect us.

The researchers, from the Texas Children's Cancer Center and Center for Cell & Gene Therapy at the Baylor College of Medicine, have harnessed this ability of NKT cells to act as a warning siren by genetically engineering them to react to a molecule often found on the surface of neuroblastoma tumours known as GD2. It is thought that these modified NKT cells will kill the tumour cells and also reactivate local immune cells that have been tricked into ignoring or even supporting the cancer.

Leonid Metelitsa, professor of paediatrics and immunology at Texas Children's Cancer Center, said: "Tumours often find ways to avoid the immune system or 'switch it off' in order to grow and survive, so any way we can switch the immune system back on and redirect it towards cancer cells would be a significant advance. By modifying these Natural Killer T cells so that they target neuroblastoma tumours and sound the alarm for the rest of the immune system we hope to have developed a new approach to treating this disease."

Neuroblastoma develops from nerve cells left over from a baby's development and there are around 100 children diagnosed with the cancer each year in the UK. Despite the number of children surviving neuroblastoma rising from 17 per cent in 1971 to 64 per cent today, the aggressive form of the disease is still very hard to treat successfully.

Dr Harpal Kumar, chief executive of Cancer Research UK and chair of the NCRI, said: "We are excited to see so much research both here and internationally into badly needed new treatments for neuroblastoma patients. Cutting edge research, such as this study, together with Cancer Research UK's newly opened trials, are making a vitally important step towards better and kinder treatments for children with neuroblastoma."

Explore further: Beta-blockers may boost chemo effect in childhood cancer

Related Stories

Beta-blockers may boost chemo effect in childhood cancer

May 22, 2013
Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Journal of ...

New hope in the fight against childhood cancer

July 11, 2013
Cancer Research UK scientists at the University of Southampton are seeing positive results in a pre-clinical trial that could bring treatments for a particular aggressive form of childhood cancer closer to reality.

Researchers discover how cancer 'invisibility cloak' works

October 28, 2013
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid (LPA) binds to killer T cells, ...

Immune system discovery could lead to EBV vaccine to prevent mono, some cancers

October 11, 2013
Development of a vaccine against Epstein-Barr virus (EBV) has taken a step forward with the Canadian discovery of how EBV infection evades detection by the immune system.

Dendritic cell vaccine for relapsed neuroblastoma patient induces complete remission

January 29, 2013
One year after his last treatment, a six-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastatic cancer. Doctors reported this case study in the January 2013 issue of Pediatrics, the ...

New strategy for defeating neuroblastoma found

June 3, 2013
Researchers at Karolinska Institutet in Sweden have found a promising strategy for defeating neuroblastoma – a malignant form of cancer in children – that focuses on the so-called MYCN protein. A specific chemical molecule ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.